Acasă › Boli autoimune › Florida

Studii clinice pentru Boli autoimune în Florida

20 studii pentru Boli autoimune caută participanți în Florida.

Orașe în Florida

Text oficial al studiului (în engleză)

Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden

Clinical Res Of W Florida, Clearwater
Clinical Research of West Florida Inc, Tampa

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 28 sept. 2026 · NCT07621809

Secukinumab Open Label Roll-over Extension Protocol

Rheumatology Associates of South Florida, Boca Raton
FL Medical Clinic Orlando Health, Zephyrhills

În curs de recrutareFaza 4

Vârste de la 6 la 100 · Toate sexele · Actualizat 28 sept. 2026 · NCT04638647

A Study of JADE101 in Participants With Immunoglobulin A Nephropathy

Jade Clinical Site, Orlando
Jade Clinical Site, Pembroke Pines

În curs de recrutareFaza 2

Vârste de la 18 la 60 · Toate sexele · Actualizat 25 sept. 2026 · NCT07541287

Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)

Miami Clinical Research, Miami
GCP Clinical Research, Tampa

În curs de recrutareFaza 2

Vârste de la 18 la 75 · Toate sexele · Actualizat 21 sept. 2026 · NCT07513181

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

Mayo Clinic Florida - Accepting Adult Patients, Jacksonville
Johns Hopkins All Children's Hospital - Accepting Juvenile Patients, St. Petersburg

În curs de recrutareFaza 2/3

Vârste de la 6 la 75 · Toate sexele · Actualizat 17 sept. 2026 · NCT06154252

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

Mayo Clinic, Jacksonville

În curs de recrutareFaza 1

Vârste de la 18 la 74 · Toate sexele · Actualizat 10 sept. 2026 · NCT07085104

PS-002 for the Treatment of IgA Nephropathy in Adults

University of Miami Hospital, Miami

În curs de recrutareFaza 1/2

Vârste de 18 ani și peste · Toate sexele · Actualizat 9 sept. 2026 · NCT07182227

A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

GSK Investigational Site, Gainesville
GSK Investigational Site, Naples

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 8 sept. 2026 · NCT06572384

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

Mayo Clinic, Jacksonville

În curs de recrutareFaza 1/2

Vârste de la 18 la 65 · Toate sexele · Actualizat 26 aug. 2026 · NCT06121297

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

Mayo Clinic Florida, Jacksonville

În curs de recrutareFaza 2/3

Vârste de la 18 la 75 · Toate sexele · Actualizat 17 aug. 2026 · NCT06328777

Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.

Nephrology Associates Of Central FL, Orlando

În curs de recrutareFaza 3

Vârste de la 18 la 100 · Toate sexele · Actualizat 17 aug. 2026 · NCT06858319

RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis

Mayo Clinic Florida, Jacksonville

În curs de recrutareFaza 1/2

Vârste de la 18 la 70 · Toate sexele · Actualizat 13 aug. 2026 · NCT06359041

A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections

University of Southern Florida, St. Petersburg

În curs de recrutareFaza 3

Vârste de 12 ani și peste · Toate sexele · Actualizat 6 aug. 2026 · NCT06056297

Study of BHV-1300 in Graves' Disease

Site-100, Miami

În curs de recrutareFaza 1

Vârste de la 18 la 65 · Toate sexele · Actualizat 31 iul. 2026 · NCT06980649

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

Site Number - 1006, Clearwater
Site Number - 1037, Ormond Beach
Site Number - 1002, Port Charlotte
și încă 2

În curs de recrutareFaza 3

Vârste de la 18 la 80 · Toate sexele · Actualizat 30 iul. 2026 · NCT07039916

KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis

University of Miami, Miami

În curs de recrutareFaza 2/3

Vârste de la 18 la 75 · Toate sexele · Actualizat 29 iul. 2026 · NCT06193889

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

University of Florida Shands Medical Center, Gainesville
Nemours Children's Hospital - Mayo Jacksonville, Jacksonville
University of Miami (peds), Miami
și încă 6

În curs de recrutareStudiu observațional

Toate vârstele · Toate sexele · Actualizat 6 iul. 2026 · NCT01351545

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

University of Florida, Gainesville
Nicklaus Children's Hospital, Miami

În curs de recrutareFaza 1

Vârste de la 12 la 70 · Toate sexele · Actualizat 22 mai 2026 · NCT06308978

A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases

University of South Florida - Carol and Frank Morsani Center of Advanced Healthcare, Tampa

În curs de recrutareFaza 1

Vârste de 18 ani și peste · Toate sexele · Actualizat 25 feb. 2026 · NCT06626919

Rheumatology Diet Study

UCF Health Clinics, Orlando

În curs de recrutareStudiu observațional

Vârste de la 18 la 65 · Toate sexele · Actualizat 6 dec. 2024 · NCT06339957

Sursă: ClinicalTrials.gov, date preluate la 3 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.